Early data on Moderna's COVID-19 vaccine insufficient: Stat News

France Nouvelles Nouvelles

Early data on Moderna's COVID-19 vaccine insufficient: Stat News
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 97%

Data from a small, early-stage safety trial testing Moderna Inc's experimental COVID-19 vaccine does not provide the critical data needed to assess its effectiveness, health-focused Stat News reported on Tuesday, citing experts.

Moderna said on Monday the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers.

Moderna later announced a stock sale that could raise about $1.5 billion, sending shares lower early on Tuesday. - lack of information about the ages of the eight subjects whose antibodies were analyzed, an important question given the virus is particularly lethal to older people

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Moderna Says Initial Covid-19 Vaccine Results Are PositiveModerna Says Initial Covid-19 Vaccine Results Are PositiveModerna said human subjects in a Phase 1 trial of a candidate Covid-19 vaccine produced immune responses that were a positive sign of the vaccine’s potential to prevent infection with the new coronavirus
Lire la suite »

Stéphane Bancel, CEO of Moderna, the biotech making a COVID-19 vaccine - Business InsiderStéphane Bancel, CEO of Moderna, the biotech making a COVID-19 vaccine - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Lire la suite »

Vaccine experts say Moderna didn't produce data critical to assessing Covid-19 vaccineVaccine experts say Moderna didn't produce data critical to assessing Covid-19 vaccineHeavy hearts soared Monday with news that Moderna's Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects.
Lire la suite »

Early data on Moderna's COVID-19 vaccine insufficient: Stat NewsEarly data on Moderna's COVID-19 vaccine insufficient: Stat NewsData from a small, early-stage safety trial testing Moderna Inc's experimental COVID-19 vaccine does not provide critical data to assess its effectiveness, Stat News reported on Tuesday, citing experts.
Lire la suite »

Amanda Kloots Celebrates a 'Small Win' Amid Husband's COVID-19 FightAmanda Kloots Celebrates a 'Small Win' Amid Husband's COVID-19 FightNick Cordero is continuing to fight the coronavirus in the hospital.
Lire la suite »



Render Time: 2025-04-03 08:51:05